MENU
ELDN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Eledon Pharmaceuticals (ELDN) Earnings Date & Reports

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis... Show more

A.I. Advisor
published Earnings

ELDN is expected to report earnings to fall 12.22% to -15 cents per share on April 01

Eledon Pharmaceuticals ELDN Stock Earnings Reports
Q4'26
Est.
$-0.16
Q3'26
Beat
by $0.02
Q2'26
Missed
by $0.12
Q1'26
Missed
by $0.15
Q4'25
Beat
by $0.10
The last earnings report on November 12 showed earnings per share of -18 cents, beating the estimate of -20 cents. With 334.00K shares outstanding, the current market capitalization sits at 211.69M.
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals

Industry Biotechnology

Industry
Pharmaceuticals Major
Address
19800 MacArthur Boulevard
Phone
+1 949 238-8090
Employees
33
Web
https://www.eledon.com